Key Drivers
- Very high gross-margin
- Large operating losses
- Elevated leverage
AIAI Summary
Axsome has transitioned into a commercial-growth company where Auvelity meaningfully de-risks near-term revenue but the investment thesis now hinges on execution to tighten rising gross-to-net (GTN) discounts and align SG&A so quarterly free-cash-flow turns positive; failure to improve GTN or curb spending amid ~2.4x leverage will likely force dilutive financing and trigger material downside. Monitor GTN rate, quarterly FCF trajectory, and cash/debt runway as the decisive short-term catalysts for upside vs. downside.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Very high gross-margin
- •Large operating losses
- •Elevated leverage
AXSM has industry-leading gross margins and a multi-quarter cash runway but is burning cash with large R&D/SG&A-driven operating losses, high leverage versus equity, negative free cash flow, and a market valuation that far exceeds fundamentals.
Price Behavior
Key Price Behavior Insights:
- •Below SMA
- •Near support
- •High volatility
Stock is in a clear near-term downtrend over the last month, trading below its last-month SMA and sitting nearer support (~$154–158) with resistance around $163–169, so a break below $154 would raise downside risk while a sustained move above $163–166 would be needed to signal a reversal.
Mid-teens percent peak-to-trough swing over the last month indicating elevated short-term volatility
Sentiment & News
Key News Insights:
- •Auvelity-driven growth
- •Wider-than-expected loss
- •Insider & institutional activity
Axsome's 2025 revenue jumped 66% to $638.5M driven by Auvelity sales, attracting investor and insider activity but still facing widened losses and analyst concerns over valuation and long‑term pipeline risk.
Strong commercial traction boosts upside potential, but profitability shortfalls and valuation scrutiny will likely keep share volatility and analyst caution in the near term
Similar Companies in Healthcare
Other companies in the same sector with AI ratings